Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine ...

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...

The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

The agency finds Zyn’s benefit as a safer alternative for adult cigarette smokers outweighs its risk to young people.

FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...

Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs.

The US Food and Drug Administration approved the marketing of 20 Zyn products to adults, the first time it has authorized ...

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...